ClearOne enters merger deal to acquire Vivani unit Cortigent

• ClearOne agreed to merge with Vivani Medical’s unit Cortigent, which will become a wholly owned subsidiary at closing.
• Vivani will receive 12,500,000 ClearOne shares; expected ownership in the combined company is 59.4% to 67.5%.
• ClearOne shareholders are expected to own 12.7% to 14.4% following the deal, depending on financing.
• ClearOne plans a concurrent Form S-1 equity raise of $10 million to $15 million tied to closing.
• ClearOne is expected to be renamed Cortigent Holdings and trade on Nasdaq under ticker CRGT; closing targeted for Q3 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ClearOne Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260702293602) on July 02, 2026, and is solely responsible for the information contained therein.